506235 Stock Overview
Engages in real estate business in India and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Alembic Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹139.50 |
52 Week High | ₹169.00 |
52 Week Low | ₹78.20 |
Beta | 1.08 |
1 Month Change | 12.36% |
3 Month Change | -2.69% |
1 Year Change | 51.38% |
3 Year Change | 38.19% |
5 Year Change | 148.88% |
Change since IPO | 3,119.23% |
Recent News & Updates
Recent updates
Shareholder Returns
506235 | IN Real Estate | IN Market | |
---|---|---|---|
7D | -5.3% | -1.8% | -4.2% |
1Y | 51.4% | 39.4% | 19.1% |
Return vs Industry: 506235 exceeded the Indian Real Estate industry which returned 39.4% over the past year.
Return vs Market: 506235 exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
506235 volatility | |
---|---|
506235 Average Weekly Movement | 5.6% |
Real Estate Industry Average Movement | 6.3% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.0% |
10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 506235 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 506235's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1907 | 285 | Malika Amin | www.alembiclimited.com |
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties.
Alembic Limited Fundamentals Summary
506235 fundamental statistics | |
---|---|
Market cap | ₹35.82b |
Earnings (TTM) | ₹3.10b |
Revenue (TTM) | ₹1.92b |
11.5x
P/E Ratio18.7x
P/S RatioIs 506235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
506235 income statement (TTM) | |
---|---|
Revenue | ₹1.92b |
Cost of Revenue | ₹693.85m |
Gross Profit | ₹1.23b |
Other Expenses | -₹1.88b |
Earnings | ₹3.10b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 12.09 |
Gross Margin | 63.87% |
Net Profit Margin | 161.61% |
Debt/Equity Ratio | 0.7% |
How did 506235 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield23%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 06:39 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alembic Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Abdulkader Puranwala | Anand Rathi Shares and Stock Brokers Limited |
Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
Manoj Garg | Emkay Global Financial Services Ltd. |